Anthem (NYSE:ANTM) Given New $584.00 Price Target at Credit Suisse Group

Anthem (NYSE:ANTMGet Rating) had its target price lifted by equities researchers at Credit Suisse Group from $518.00 to $584.00 in a research report issued on Thursday, The Fly reports. Credit Suisse Group’s price target would indicate a potential upside of 10.22% from the stock’s current price.

Several other research firms also recently weighed in on ANTM. SVB Leerink upped their price target on Anthem from $465.00 to $483.00 and gave the stock a “market perform” rating in a research note on Tuesday, March 15th. Jefferies Financial Group restated a “buy” rating and issued a $559.00 price target on shares of Anthem in a research note on Tuesday, March 29th. Argus upped their price target on Anthem from $475.00 to $500.00 and gave the stock a “buy” rating in a research note on Monday, February 7th. Sanford C. Bernstein upped their price target on Anthem from $559.00 to $574.00 in a research note on Tuesday, January 11th. Finally, StockNews.com initiated coverage on Anthem in a research report on Thursday, March 31st. They issued a “strong-buy” rating on the stock. Two analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $499.10.

ANTM stock opened at $529.84 on Thursday. Anthem has a fifty-two week low of $355.43 and a fifty-two week high of $532.16. The business’s 50 day moving average price is $477.39 and its two-hundred day moving average price is $446.51. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.47 and a current ratio of 1.47. The company has a market capitalization of $134.19 billion, a price-to-earnings ratio of 21.43, a price-to-earnings-growth ratio of 1.46 and a beta of 1.05.

Anthem (NYSE:ANTMGet Rating) last posted its quarterly earnings results on Wednesday, April 20th. The company reported $8.25 earnings per share for the quarter, topping the consensus estimate of $7.81 by $0.44. The company had revenue of $38.10 billion for the quarter, compared to the consensus estimate of $37.28 billion. Anthem had a return on equity of 18.20% and a net margin of 4.40%. The firm’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $7.01 EPS. Sell-side analysts forecast that Anthem will post 28.49 earnings per share for the current year.

In other Anthem news, CAO Ronald W. Penczek sold 2,763 shares of the stock in a transaction on Monday, February 7th. The stock was sold at an average price of $453.48, for a total value of $1,252,965.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Ronald W. Penczek sold 2,423 shares of the stock in a transaction on Thursday, March 3rd. The stock was sold at an average price of $463.68, for a total value of $1,123,496.64. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 22,889 shares of company stock worth $10,532,411. 0.27% of the stock is owned by insiders.

Several institutional investors have recently modified their holdings of the company. StrategIQ Financial Group LLC purchased a new position in shares of Anthem during the first quarter valued at about $205,000. Riverview Trust Co purchased a new position in shares of Anthem during the first quarter valued at about $60,000. BNC Wealth Management LLC purchased a new position in shares of Anthem during the first quarter valued at about $1,924,000. Bank of New Hampshire purchased a new position in shares of Anthem during the first quarter valued at about $52,000. Finally, Xponance Inc. grew its position in shares of Anthem by 4.9% during the first quarter. Xponance Inc. now owns 16,749 shares of the company’s stock valued at $8,227,000 after purchasing an additional 784 shares in the last quarter. Hedge funds and other institutional investors own 87.97% of the company’s stock.

About Anthem (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Featured Stories

The Fly logo

Analyst Recommendations for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.